ELEVANCE HEALTH, INC.
Hospital & Medical Service Plans- 売上
- $199bn
- 時価総額
- $85.6bn
株価 $376.40 · 100株 4万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $171bn | $177bn | $199bn |
| 成長率 | — | 3.3% | 12.5% |
| 総利益 | $154bn | $157bn | $178bn |
| 総利益率 | 89.9% | 88.8% | 89.4% |
| 販管費 | $20.1bn | $20.0bn | $21.0bn |
| 販管費率 | 11.7% | 11.3% | 10.5% |
| 営利 | $8.5bn | $7.9bn | $7.2bn |
| 営利率 | 5.0% | 4.4% | 3.6% |
| 純利益 | $6.0bn | $6.0bn | $5.7bn |
| PBR | 2.2 | 2.1 | 2.0 |
| PSR | 0.5 | 0.5 | 0.4 |
| PGPR | 0.6 | 0.5 | 0.5 |
| PER | 14 | 14 | 15 |
| ネットキャッシュ | ▲$18.4bn | ▲$22.6bn | ▲$22.4bn |
| EV/EBITDA | 10.1 | 11.7 | 12.3 |
| Rule of 40 | — | 8% | 16% |
| セールス効率 | — | — | 2,157% |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
